Ignite Creation Date:
2024-05-06 @ 3:56 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02418624
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2015-03-09
Brief Title:
Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Organization Data
Organization:
The Netherlands Cancer Institute
Class:
OTHER
Study ID:
M14REV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Netherlands Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None